Cradle Analysis: $73M Raised
What is Cradle?
Cradle specializes in leveraging artificial intelligence to generate and optimize protein candidates. Their unique approach combines experimental data with AI to accelerate protein design and development. This results in faster breakthroughs and reduced experimental timelines for various applications in therapeutics and agriculture.
Employees
11-50
Founded
2021
Industry
AI/ML, Biotech, Agtech
Latest Funding Round Size
$73,000,000
Product Features & Capabilities
- AI-based protein design platform for candidate generation
- Multi-property optimization for diverse protein characteristics
- Comprehensive reporting tools for tracking experimental results
- Secure data management with full ownership of intellectual property
- Custom model training based on proprietary experimental data.
Use Cases
Generate optimized protein candidates for laboratory testing; Accelerate protein development timelines for therapeutic applications; Co-optimize multiple protein properties simultaneously; Validate AI-generated candidates in real-world lab settings; Manage and analyze experimental data efficiently.
How much Cradle raised
Series B - $73,000,000
RecentOther Considerations
Trusted by major companies like Novo Nordisk and Johnson & Johnson; Operates a wet lab in Amsterdam for model validation; Fully SOC 2 compliant with strong data security measures.
See something that needs updating? Suggest edits to this profile.
